NexTech Brings AR to Healthcare & Cannabis Industries


Ryan Allway

March 14th, 2019

Exclusive, News, Top News


There’s no doubt that augmented reality (AR) is gaining traction among consumers. For example, many experts attribute Snap Inc.’s (NYSE: SNAP) success to its unique augmented reality capabilities. Many ecommerce businesses have also found that augmented reality can dramatically improve conversion rates and reduce returns by enabling consumers to “try before they buy” clothing, furniture, and other items.

NexTech AR Solutions (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29) has developed a next generation augmented reality (AR) platform that makes these capabilities easier than ever for businesses of all sizes rather than just the giants. With nothing more than a code snippet, these organization can access state-of-the-art AR functionality for an affordable monthly price—a compelling value proposition for many businesses.

Partnership with Premier Health

NexTech AR Solutions recently announced that it’s working with Premier Health (CSE: PHGI) (OTCQB: PHGRF) (FFT: 6PH) by exploring the integration of its AR technology into the Premier Health App, which has the potential to reach nearly three million patients. In particular, the two companies are focused on developing educational tools for healthcare professionals and patients, including third parties.

“We are excited to work with the team at Premier Health to explore creating a custom AR and AI solution to address the healthcare market which represents another multi-billion dollar vertical ripe for disruption,” said Evan Gappelberg, CEO of NexTech, in a recent press release. “AR allows medical knowledge, skills and expertise to be shared remotely in the moment, ensuring they get where they are needed most.”

The companies hope to leverage AR to develop tools to help train healthcare professionals with highly-engaging and immersive educational experiences, which improves retention and better conveys complex concepts. In addition, the companies will develop AR tools to help patients take a more proactive role in their own care by assisting with self-diagnosis, medical device usage, and medical usage.

Next Generation AR Dispensaries

NexTech AR Solutions further announced the launch of its innovative AR platform for the legal cannabis industry—AR Dispensary. AR Dispensary leverages immersive AR technology and rich 3D 360-degree photography to provide an ecommerce experience that’s unmatched in the cannabis industry. The white label solution integrates into a dispensary’s website with a small code snippet, enabling consumers to preview their full line of products.

“As an end-to-end eCommerce and education solution for the legal cannabis industry, AR Dispensary provides dispensary owners with a comprehensive solution that is scalable, customizable and, most importantly, easy to integrate within an existing web interface,” said Evan Gappelberg, CEO of NexTech. “Whether a dispensary’s goal is to educate customers on potential health benefits of cannabis or simply to increase sales, AR Dispensary provides the interactive online experience consumers crave that drives brand loyalty and awareness.”

The inclusion of AR technology represents a more scalable way to educate customers compared to traditional budtenders—especially in an industry where many first-time buyers don’t know where to start. Before even entering the dispensary, consumers can use the AR powered website to have a much clearer vision of what they need, enabling them to make instant purchase decisions without the need for costly manual support.

Looking Ahead

NexTech AR Solutions (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29) continues to expand into new industries. After its initial launch in the cannabis industry, the company moved on to launch ecommerce and fashion products before targeting the healthcare industry with its most recent announcements. The company also continues to innovate in each of these markets, as evidenced by the launch of its AR Dispensary product.

For more information, visit the company’s website at www.nextechar.com.

Disclaimer

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading